Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

Author： Stein Dan J.   Andersen Elisabeth Wreford   Tonnoir Brigitte   Fineberg Naomi  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.4, 2007-04, pp. : 701-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED, FIXED‐DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 6, 2015-06 ,pp. : 451-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inference-Based Approach versus Cognitive Behavioral Therapy in the Treatment of Obsessive-Compulsive Disorder with Poor Insight: A 24-Session Randomized Controlled Trial

By  

Psychotherapy and Psychosomatics, Vol. 84, Iss. 5, 2015-08 ,pp. : 284-293

Karger

Access to resources Recommend Favorite

A Randomized Controlled Trial of Japanese Patients with Obsessive-Compulsive Disorder – Effectiveness of Behavior Therapy and Fluvoxamine

By  

Psychotherapy and Psychosomatics, Vol. 74, Iss. 5, 2005-08 ,pp. : 269-276

Karger

Access to resources Recommend Favorite

Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study

By Trugman Joel M.   Palmer Robert H.   Ma Yimin  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite

Shared Obsessive-Compulsive Disorder

By  

Psychopathology, Vol. 39, Iss. 2, 2006-02 ,pp. : 99-101

Karger

Access to resources Recommend Favorite